Brain Trust Accelerator Fund

About The Fund

The Brain Trust Accelerator Fund is a venture capital firm that specializes in translational stage investments, particularly focusing on projects that aim to advance the diagnosis and treatment of brain-related diseases. Established in 2006 and headquartered in Burlingame, California, the fund operates with the objective to impact the biotechnology and medical sectors. The scope of their investment targets includes but is not limited to the BioTech industry and Medical Devices, including Hospital Services. Through their focused investment strategy, they address crucial healthcare challenges by supporting innovations in the field of brain health. Over the course of its operation, Brain Trust Accelerator Fund's first fund (Fund I) has achieved top-tier rates of return. Additionally, the investments have had substantial impact, with outputs from funded projects expected to benefit up to ten million patients suffering from various brain diseases. The fund's investment approach also encompasses an element of impact investing with their success measured not only in financial returns but also in terms of positive societal contributions. This is exemplified by their significant financial contributions of $500,000 to charities. As the fund's portfolio continues to evolve, their anticipation for the performance of Fund II remains high, following the promising pattern established by the inaugural fund. The Brain Trust Accelerator Fund prides itself on its dual-purpose mission of fostering business growth in the biotech arena, while simultaneously effectuating philanthropic engagement by supporting meaningful causes related to their core focus of brain disease.